NCT07472725

A Study Comparing Safety and Efficacy of SHR-3167 Fixed-Dose Titration and Individualized-Dose Titration in Adults With Type 2 Diabetes Inadequately Controlled With Oral Antihyperglycemic Agents

A Randomized, Open-Label, Treat-to-Target, Parallel-Controlled Phase II Clinical Study to Evaluate the Safety and Efficacy of Fixed-Dose Titration and Individualized-Dose Titration of SHR-3167 in Adults With Type 2 Diabetes Inadequately Controlled With Oral Antihyperglycemic Agents

• Status: Not Yet Recruiting
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 90 (estimated)
• Sponsor: Jiangsu HengRui Medicine Co., Ltd. · Industry
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to evaluate the safety and glycemic control of SHR-3167 fixed-dose titration and individualized-dose titration in adults with Type 2 Diabetes inadequately controlled with oral antihyperglycemic agents.

Conditions

• Diabetes Mellitus, Type 2

Interventions

Type	Name	Description
DRUG	SHR-3167 Injection	SHR-3167 injection.
DRUG	SHR-3167 Injection Placebo	SHR-3167 injection placebo.

Timeline

• Start date: 2026-04-01
• Primary completion: 2026-12-01
• Completion: 2027-02-01
• First posted: 2026-03-16
• Last updated: 2026-03-16

Locations

2 sites across 1 country: China